Table 1 Description of included guidelines

Topic

Prediction and prevention of spontaneous preterm birth

6

26

28

60 (23.1)

Prediction and prevention of provider-initiated preterm birth

21

46

73

140 (53.8)

Optimisation and management of preterm birth

2

8

50

60 (23.1)

Developer

Government department

0

7

4

11 (4.2)

Academic institution

0

2

1

3 (1.2)

Colleges, societies and other professional organisations

29

71

12

112 (43.1)

District health boards

0

0

134

134 (51.5)

Funding source

Internal (by developer)

2

31

10

43 (16.5)

External

12

21

2

35 (13.5)

None/not reported

15

28

139

182 (70.0)

Use of equity tool in guideline development process

Equity tool used

3

6

2

11 (4.2)

None/not reported

26

74

149

249 (95.8)

Consumer involvement in guideline development process

Member of guideline development group

1

37

11

49 (18.8)

Consultation

4

9

1

14 (5.4)

None/not reported

24

34

139

197 (75.8)

Indigenous (Māori) representation in guideline development process

Member of guideline development group

0

6

3

9 (3.5)

Consultation

0

1

1

2 (0.8)

None/not reported

29

73

147

249 (95.8)

Format of publication

Guideline

29

49

125

203 (78.0)

Consensus statement/ consensus position statement/ position statement/ best practice statement

0

30

18

48 (18.5)

Manual/protocol

0

1

1

2 (0.8)

Not stated

0

0

7

7 (2.6)

Region

New Zealand

1

25

141

167 (64.2)

Australasian

4

30

7

41 (15.8)

International

24

25

3

52 (20.0)

Sources of evidence

Evidence documented

14

32

9

55 (21.2)

Adapted/adopted/contextualised

0

1

8

9 (3.5)

Not evidence documented/not reported

15

47

134

196 (75.4)

Currency

Within 5 years

16

42

128

186 (71.5)

Older than 5 years

13

38

23

74 (28.5)

Implementation plan

Resources for implementation

12

22

94

128 (49.2)

Implementation plan

7

20

4

31 (11.9)

None

10

38

53

101 (38.8)